Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $600,000 | 3 | 96.3% |
| Consulting Fee | $20,500 | 1 | 3.3% |
| Travel and Lodging | $1,377 | 6 | 0.2% |
| Food and Beverage | $915.26 | 23 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Omnia Medical, LLC | $620,500 | 4 | $0 (2023) |
| Medtronic USA, Inc. | $1,763 | 16 | $0 (2020) |
| Abbott Laboratories | $140.66 | 1 | $0 (2024) |
| Boston Scientific Corporation | $129.39 | 1 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $58.55 | 1 | $0 (2021) |
| PFIZER INC. | $42.11 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $32.65 | 2 | $0 (2017) |
| Stryker Corporation | $32.23 | 1 | $0 (2017) |
| Alphatec Spine, Inc | $28.53 | 1 | $0 (2019) |
| Integra LifeSciences Corporation | $23.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140.66 | 1 | Abbott Laboratories ($140.66) |
| 2023 | $200,129 | 2 | Omnia Medical, LLC ($200,000) |
| 2022 | $200,020 | 2 | Omnia Medical, LLC ($200,000) |
| 2021 | $220,559 | 3 | Omnia Medical, LLC ($220,500) |
| 2020 | $61.46 | 3 | Medtronic USA, Inc. ($40.36) |
| 2019 | $52.36 | 2 | Alphatec Spine, Inc ($28.53) |
| 2018 | $31.26 | 2 | PFIZER INC. ($31.26) |
| 2017 | $1,799 | 18 | Medtronic USA, Inc. ($1,723) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $140.66 | General |
| Category: Neuromodulation | ||||||
| 02/15/2023 | Omnia Medical, LLC | — | Acquisitions | Cash or cash equivalent | $200,000.00 | General |
| 02/15/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $129.39 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/31/2022 | ZIMVIE INC. | Mobi-C (Device) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Spine | ||||||
| 02/15/2022 | Omnia Medical, LLC | — | Acquisitions | Cash or cash equivalent | $200,000.00 | General |
| 09/09/2021 | Zimmer Biomet Holdings, Inc. | Lineum Posterior Cervical (Device) | Food and Beverage | Cash or cash equivalent | $58.55 | General |
| Category: Spine | ||||||
| 07/07/2021 | Omnia Medical, LLC | — | Consulting Fee | Cash or cash equivalent | $20,500.00 | General |
| 02/15/2021 | Omnia Medical, LLC | — | Acquisitions | Cash or cash equivalent | $200,000.00 | General |
| 10/22/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/05/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/22/2020 | Arbor Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Sleep | ||||||
| 05/15/2019 | Alphatec Spine, Inc | SQUADRON (Device) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 01/23/2019 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, DURAGEN | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: NEURO CRITICAL CARE | ||||||
| 11/09/2018 | PFIZER INC. | GELFOAM (Device) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: HEMOSTAT | ||||||
| 07/16/2018 | PFIZER INC. | THROMBIN (Biological), GELFOAM | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: HEMOSTAT | ||||||
| 12/14/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Food and Beverage | In-kind items and services | $114.70 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/17/2017 | PFIZER INC. | THROMBIN (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: HEMOSTAT | ||||||
| 11/10/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Travel and Lodging | In-kind items and services | $143.99 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/10/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/10/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Travel and Lodging | In-kind items and services | $34.71 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/10/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/10/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/09/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Food and Beverage | In-kind items and services | $83.00 | General |
| Category: Image Guided Surgery Products | ||||||
| 11/07/2017 | Medtronic USA, Inc. | O-ARM-ST (Device) | Travel and Lodging | In-kind items and services | $283.10 | General |
| Category: Image Guided Surgery Products | ||||||
| 10/17/2017 | Medtronic USA, Inc. | ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 734 | 2,313 | $526,316 | $157,331 |
| 2022 | 19 | 1,048 | 1,938 | $624,902 | $164,977 |
| 2021 | 18 | 1,277 | 2,898 | $641,368 | $213,223 |
| 2020 | 17 | 1,339 | 2,608 | $445,558 | $159,136 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 253 | 1,513 | $234,893 | $91,885 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 198 | $82,169 | $16,626 | 20.2% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 2023 | 48 | 179 | $56,578 | $13,330 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 79 | $45,740 | $10,373 | 22.7% |
| G0427 | Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | Office | 2023 | 45 | 46 | $27,477 | $5,921 | 21.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 49 | 49 | $15,435 | $5,367 | 34.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 53 | $20,612 | $4,785 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $23,145 | $4,622 | 20.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 29 | 138 | $18,727 | $4,036 | 21.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 15 | $1,540 | $386.78 | 25.1% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Facility | 2022 | 107 | 346 | $109,488 | $26,530 | 24.2% |
| G0427 | Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | Facility | 2022 | 160 | 165 | $101,574 | $23,973 | 23.6% |
| 61312 | Removal of skull bone for aspiration of blood accumulation in upper brain outside or below brain membrane | Facility | 2022 | 11 | 12 | $57,197 | $18,404 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 179 | $69,701 | $16,009 | 23.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 78 | $46,056 | $11,784 | 25.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 42 | 301 | $29,977 | $9,004 | 30.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 88 | 131 | $20,333 | $7,980 | 39.2% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 2022 | 27 | 97 | $30,695 | $7,453 | 24.3% |
| G0427 | Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | Office | 2022 | 47 | 49 | $30,164 | $7,135 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $29,228 | $6,533 | 22.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 67 | $20,297 | $5,248 | 25.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 70 | 117 | $13,440 | $5,147 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 76 | $21,369 | $4,658 | 21.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 25 | 98 | $9,334 | $3,721 | 39.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 14 | 17 | $12,192 | $3,672 | 30.1% |
About Dr. Clinton Baird, M.D
Dr. Clinton Baird, M.D is a Neurological Surgery healthcare provider based in Georgetown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972656908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clinton Baird, M.D has received a total of $622,792 in payments from pharmaceutical and medical device companies, with $140.66 received in 2024. These payments were reported across 33 transactions from 12 companies. The most common payment nature is "Acquisitions" ($600,000).
As a Medicare-enrolled provider, Baird has provided services to 4,398 Medicare beneficiaries, totaling 9,757 services with total Medicare billing of $694,668. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Neurological Surgery
- Location Georgetown, TX
- Active Since 01/21/2007
- Last Updated 01/12/2026
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1972656908
Products in Payments
- VISUALASE (Device) $964.41
- O-ARM-ST (Device) $741.50
- PROCLAIM (Device) $140.66
- Lineum Posterior Cervical (Device) $58.55
- INTELLIS (Device) $40.36
- ACCULIF (Device) $32.23
- SQUADRON (Device) $28.53
- CODMAN CERTAS (Device) $23.83
- Horizant (Drug) $21.10
- Mobi-C (Device) $19.58
- Movantik (Drug) $19.55
- THROMBIN (Biological) $18.15
- ADAPTIVESTIM (Device) $16.90
- GELFOAM (Device) $13.11
- INJECTAFER (Drug) $13.10
- THROMBIN (Drug) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.